What is the half-life of Vilon?

Vilon has a half-life of ~30-60 minutes, which is why it's typically administered Once daily for 10-15 day cycles for optimal therapeutic effect.

How do I reconstitute Vilon?

Add bacteriostatic water to the peptide vial slowly down the side. Typical reconstitution uses 2-3ml of water for a 5mg vial. Gently swirl, do not shake.

Anti-Ageing

Preclinical

Vilon

Also known as: KE dipeptide, Lys-Glu, T-38

Overview

Key Facts

Primary Goal: An ultra-short bioregulator peptide consisting of just two amino acids (lysine-glutamic acid) developed by the Khavinson research group

An ultra-short bioregulator peptide consisting of just two amino acids (lysine-glutamic acid) developed by the Khavinson research group. Despite its minimal size, Vilon demonstrates significant immunomodulatory and gene-regulatory effects, particularly on thymic function and T-cell immunity. It represents the smallest known peptide with documented bioregulatory activity. Half-Life ~30-60 minutes Typical Dose 0.5–1 mg Frequency Once daily for 10-15 day cycles Cycle Length 10-15 days on, 3-6 months off

Dosing Information

Half-Life

~30-60 minutes

Typical Dose

0.5–1 mg

Frequency

Once daily for 10-15 day cycles

Cycle Length

10-15 days on, 3-6 months off

Administration Routes:

subcutaneousoral

Storage & Reconstitution

Unreconstituted (Powder)

Temperature15–25°C (59–77°F)

DurationUp to 3 months

Reconstituted (Mixed)

Temperature15–25°C (59–77°F)

Duration2-4 weeks

Research Summary

Preclinical

Research by the St. Petersburg Institute of Bioregulation and Gerontology has shown that Vilon can modulate expression of genes involved in immune regulation, cell differentiation, and apoptosis. Studies in aged animals demonstrated restored thymic structure and function. The dipeptide's ability to exert biological effects despite its tiny size challenges conventional pharmacological assumptions and has implications for oral peptide drug development. Published data spans over two decades of Russian bioregulatory research.